Skip to content

Yoga for Persons With Severe Visual Impairment

Development of a Yoga Intervention for Symptoms Related to Severe Visual Impairment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01366677
Acronym
RPY
Enrollment
21
Registered
2011-06-06
Start date
2010-08-31
Completion date
2013-12-31
Last updated
2014-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Balance Impairment, Depression, Sleep Disturbance, Stress

Brief summary

This study aims to provide novel information on the feasibility of yoga interventions for secondary symptoms related to severe vision loss, such as sleep disturbances, negative mood states, fall risk and balance. This information will be important for determining safe, cost-effective and reliable practices for the benefits of yoga as an alternative means for improved health and well-being. A yoga intervention that is integrative and evidence-based will benefit the blind population through effective treatments and prevention of secondary symptoms as well as serve to inform rehabilitation specialists, educators, and clinicians in the future.

Detailed description

This study aims to provide novel information on the feasibility of yoga interventions for secondary symptoms related to severe vision loss, such as sleep disturbances, negative mood states, fall risk and balance. This information will be important for determining safe, cost-effective and reliable practices for the benefits of yoga as an alternative means for improved health and well-being. A yoga intervention that is integrative and evidence-based will benefit the blind population through effective treatments and prevention of secondary symptoms as well as serve to inform rehabilitation specialists, educators, and clinicians in the future.

Interventions

BEHAVIORALYoga Intervention

Three yoga classes per week for 8 weeks.

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18+ * Legal blindness (visual acuity worse than 20/200 but better than no/bare light perception, and/or visual field less than 20º, in the better eye) * Any ocular disease diagnosis that is expected to remain relatively stable throughout a 3-6 month period * Being healthy to the extent that participation yoga therapy would not exacerbate any existing disease conditions; * Willingness to participate on a weekly basis for the 12-week intervention; * Moderate to severe sleep disturbances, defined as ratings of 5 or greater on the PSQI

Exclusion criteria

* Significant changes to vision within the most recent 3-month period * Inability to understand study procedures or communicate responses to visual stimuli in a consistent manner * Clinically diagnosed or clinically significant sleep disorder (e.g., sleep apnea) or a medical or psychiatric condition (e.g., chronic pain) responsible for sleep complaints; * Use of prescription sleep medication more than once a week for duration of the study; * Use of other psychotropic medication; * Current recipient of sleep disorder treatment; * Consumption of more than 2-3 alcoholic beverages per day * Smoking more than 10 cigarettes per day;

Design outcomes

Primary

MeasureTime frameDescription
Static BalanceWeek 0 and Week 8.Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.

Secondary

MeasureTime frameDescription
Perceived Stress ScaleWeek 0 and Week 8Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.
Profile of Mood States - Short FormWeek 0 and Week 8Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.
Exit SurveyWeek 8The exist survey is administered immediately after the intervention during Week 8.
Fear of Falling QuestionnaireWeek 0 and Week 8Measures will be assessed at baseline (Week 0) and immediately after the 8-week intervention at Week 8.

Other

MeasureTime frameDescription
Treatment ValidationWeek 0, Week 4 and Week 8Three measures will be collected to assess the benefits of the AYT, compliance, fidelity of treatment and evaluate the participant's experience. 1. The Philadelphia Mindfulness Scale (PHLMS). 2. Practice/Homework Logs. 3. Treatment Fidelity.
Physical FunctionWeek 0 and Week 8Body Mass Index (BMI), systemic blood pressure, and respiratory rate, the International Physical Activity Questionnaire (IPAQ) and flexibility measures.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026